Vanguard Group’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $494K | Buy |
|
|||||
|
2025
Q1 | $375K | Buy |
|
|||||
|
2024
Q4 | $1.06M | Buy |
|
|||||
|
2024
Q3 | $746K | Hold |
|
|||||
|
2024
Q2 | $857K | Buy |
|
|||||
|
2024
Q1 | $801K | Buy |
|
|||||
|
2023
Q4 | $685K | Buy |
|
|||||
|
2023
Q3 | $615K | Buy |
|
|||||
|
2023
Q2 | $799K | Buy |
|
|||||
|
2023
Q1 | $309K | Hold |
|
|||||
|
2022
Q4 | $414K | Buy |
|
|||||
|
2022
Q3 | $491K | Sell |
|
|||||
|
2022
Q2 | $1.05M | Buy |
|
|||||
|
2022
Q1 | $2.71M | Buy |
|
|||||
|
2021
Q4 | $5.33M | Buy |
|